Diversified Tracked since Q3 FY26 - Q3 FY26

Sanofi India Ltd

SANOFIINDIA

Latest quarter Q3 FY26

Revenue ₹1,511 Cr

Management credibility Building

Promise tracking available after 2+ quarters of coverage.

View all executive profiles for Sanofi India Ltd

Latest signal neutral medium

Sanofi India reported a mixed Q4 FY26 with domestic sales of ₹1,511 crore for FY25, driven by 11% YoY growth in the d...

Quarterly Earnings Timeline

Financial verification status, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q3 FY26 10 Feb 2026

Revenue ₹1,511 Cr

Sanofi India reported a mixed Q4 FY26 with domestic sales of ₹1,511 crore for FY25, driven by 11% YoY growth in the diabetes segment, led by insulin portfolio (Lantus,...

neutral medium

Scorecard starts after historical backfill Read full analysis →